Predictors of hospital length of stay, discharge disposition, and readmission after craniopharyngioma surgery: a multicenter study from the RAPID database. Neurosurg Focus 2026 Jun 01;60(6):E6
Date
06/01/2026Pubmed ID
42224727DOI
10.3171/2026.2.FOCUS251047Scopus ID
2-s2.0-105040842681 (requires institutional sign-in at Scopus site)Abstract
OBJECTIVE: Craniopharyngiomas are benign intracranial tumors that can be difficult to manage operatively and often result in postoperative complications and prolonged recovery. Understanding the factors that influence length of stay (LOS), discharge disposition, and readmission can guide perioperative planning and patient counseling. The authors examined the clinical, radiographic, and surgical predictors of extended LOS (eLOS), nonhome discharge, 90-day readmission, and hospitalization ratio (HR) after craniopharyngioma resection using a large, multicenter cohort.
METHODS: A retrospective analysis was conducted using the Registry of Adenomas of the Pituitary and Related Disorders database, encompassing 469 patients who underwent craniopharyngioma resection at 14 US academic centers from 2011 to 2025. Patients were stratified by 4 outcomes: eLOS (> 75th percentile), discharge to home versus skilled nursing facility/rehabilitation, 90-day hospital readmission, and hospitalization ratio (i.e., integration of initial and readmission LOS). Multivariable logistic regression models identified independent predictors for each outcome among patient and surgical variables.
RESULTS: An eLOS (> 10 days) was independently associated with preoperative memory loss (OR 3.75, 95% CI 1.95-7.21), gait imbalance (OR 5.90, 95% CI 1.53-22.70), and postoperative complications (OR 4.07, 95% CI 2.34-7.06). The use of a nasoseptal flap was protective against an eLOS (OR 0.52, 95% CI 0.28-0.93). Discharge to home was predicted by an endoscopic approach (OR 3.87, 95% CI 1.78-8.44) and postoperative intact thirst (OR 2.22, 95% CI 1.05-4.66) and negatively predicted by preoperative diabetes mellitus (OR 0.21, 95% CI 0.09-0.50), LOS (OR 0.87, 95% CI 0.84-0.91), and postoperative cognitive dysfunction (OR 0.30, 95% CI 0.13-0.72). Among 385 patients with follow-up data, a 90-day readmission was independently associated with postoperative complications (OR 5.62, 95% CI 3.12-10.13), preexisting coronary artery disease (OR 4.30, 95% CI 1.46-12.69), and postoperative cognitive dysfunction (OR 3.33, 95% CI 1.76-6.44). A higher HR was associated with diabetes mellitus (unstandardized B 0.059, 95% CI 0.010-0.108, p = 0.02), postoperative complications (unstandardized B 0.054, 95% CI 0.021-0.086, p = 0.001), and postoperative cognitive dysfunction (unstandardized B 0.049, 95% CI 0.006-0.092, p = 0.02). Tumor pathologic subtype and size, prior treatment, extent of resection, and surgeon experience were not directly predictive of outcomes.
CONCLUSIONS: Cognitive and functional status, systemic comorbidities, and postoperative complications, in addition to surgical approach, are important predictors of the early clinical course after craniopharyngioma surgery. Early identification of high-risk patients may help to guide treatment decisions, improve discharge planning, and reduce healthcare utilization.
Author List
Tenhoeve SA, Tang A, Orton CJ, Gautam D, Abdul-Rahman NH, Silverstein JM, Kim AH, Evans JJ, Barkhoudarian G, Fernandez-Miranda JC, Pacione DR, Kim W, Bergsneider M, Chicoine MR, Zada G, Kshettry VR, Wu KC, Benjamin CG, Van Gompel J, Palit SR, Catalino MP, Mamelak AN, Zwagerman NT, Cheok SK, Little AS, Zenonos GA, Karsy M, Morshed RA, Blackburn SL, Mukherjee D, Beer-Furlan A, Couldwell WT, Gardner PA, Rennert RCAuthors
Stephanie K. Cheok MD Assistant Professor in the Neurosurgery department at Medical College of WisconsinNathan Zwagerman MD Associate Professor in the Neurosurgery department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAged
Cohort Studies
Craniopharyngioma
Databases, Factual
Female
Humans
Length of Stay
Male
Middle Aged
Neurosurgical Procedures
Patient Discharge
Patient Readmission
Pituitary Neoplasms
Postoperative Complications
Retrospective Studies









